Literature DB >> 9740666

Mapping an endometrial cancer tumor suppressor gene at 10q25 and development of a bacterial clone contig for the consensus deletion interval.

S Peiffer-Schneider1, F C Noonan, D G Mutch, S B Simpkins, T Herzog, J Rader, A Elbendary, D J Gersell, K Call, P J Goodfellow.   

Abstract

Frequent loss of chromosome 10q sequences in endometrial cancers suggests the involvement of a tumor suppressor gene. Previous loss-of-heterozygosity (LOH)studies have pointed to the 10q25-q26 region as the likely site of a tumor suppressor involved in endometrial tumorigenesis (S. L. Peiffer et al., 1995, Cancer Res. 55: 1922-1926; S. Nagase et al., 1996, Br. J. Cancer 74: 1979-1983; S. Nagase et al.,1997, Cancer Res. 57: 1630-1633). In an attempt to define further the localization of a tumor suppressor gene at 10q25, we screened a panel of 123 endometrioid adenocarcinomas for loss of heterozygosity of 10q25.3 sequences. Forty-three (35%) revealed LOH at one or more loci. The observed patterns of allelic loss define a minimum consensus region of deletion between D10S221 and D10S610. A sequence-ready bacterial clone contig and a long-range restriction map for a 1-Mb interval spanning the deletion region were developed as the first step in experiments directed toward the discovery the 10q25 tumor suppressor. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740666     DOI: 10.1006/geno.1998.5399

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  7 in total

1.  Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26.

Authors:  Susan A Treloar; Jacqueline Wicks; Dale R Nyholt; Grant W Montgomery; Melanie Bahlo; Vicki Smith; Gary Dawson; Ian J Mackay; Daniel E Weeks; Simon T Bennett; Alisoun Carey; Kelly R Ewen-White; David L Duffy; Daniel T O'connor; David H Barlow; Nicholas G Martin; Stephen H Kennedy
Journal:  Am J Hum Genet       Date:  2005-07-21       Impact factor: 11.025

2.  Tissue selective estrogen complexes (TSECs) differentially modulate markers of proliferation and differentiation in endometrial cells.

Authors:  Jaime Kulak; Rui A Ferriani; Barry S Komm; Hugh S Taylor
Journal:  Reprod Sci       Date:  2012-11-20       Impact factor: 3.060

3.  Regulation of sarcomagenesis by the empty spiracles homeobox genes EMX1 and EMX2.

Authors:  Manuel Pedro Jimenez-García; Antonio Lucena-Cacace; Daniel Otero-Albiol; Amancio Carnero
Journal:  Cell Death Dis       Date:  2021-05-20       Impact factor: 8.469

4.  SKY analysis revealed recurrent numerical and structural chromosome changes in BDII rat endometrial carcinomas.

Authors:  Eva Falck; Carola Hedberg; Karin Klinga-Levan; Afrouz Behboudi
Journal:  Cancer Cell Int       Date:  2011-06-27       Impact factor: 5.722

Review 5.  The Role of Chromosomal Instability in Cancer and Therapeutic Responses.

Authors:  Natalia Vargas-Rondón; Victoria E Villegas; Milena Rondón-Lagos
Journal:  Cancers (Basel)       Date:  2017-12-28       Impact factor: 6.639

6.  The expression of EMX2 lead to cell cycle arrest in glioblastoma cell line.

Authors:  Annabelle Monnier; Rachel Boniface; Régis Bouvet; Amandine Etcheverry; Marc Aubry; Tony Avril; Véronique Quillien; Eric Chevet; Jean Mosser
Journal:  BMC Cancer       Date:  2018-12-04       Impact factor: 4.430

7.  Empty spiracles homeobox genes EMX1 and EMX2 regulate WNT pathway activation in sarcomagenesis.

Authors:  Manuel Pedro Jimenez-García; Antonio Lucena-Cacace; Daniel Otero-Albiol; Amancio Carnero
Journal:  J Exp Clin Cancer Res       Date:  2021-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.